These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Takada T; Amano H; Yasuda H; Nimura Y; Matsushiro T; Kato H; Nagakawa T; Nakayama T; Cancer; 2002 Oct; 95(8):1685-95. PubMed ID: 12365016 [TBL] [Abstract][Full Text] [Related]
4. Chemotherapy of advanced measurable colon and rectal carcinoma with oral 5-fluorouracil, alone or in combination with cyclophosphamide or 6-thioguanine, with intravenous 5-fluorouracil or beta-2'-deoxythioguanosine or with oral 3(4-methyl-cyclohexyl)-1(2-chlorethyl)-1-nitrosourea: a Phase II-III study of the Eastern Cooperative Oncology Group (EST 4273). Douglass HO; Lavin PT; Woll J; Conroy JF; Carbone P Cancer; 1978 Dec; 42(6):2538-45. PubMed ID: 365312 [TBL] [Abstract][Full Text] [Related]
5. Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study. Windschitl H; Scott M; Schutt A; McCormack G; Everson L; Cullinan S; Gerstner J; Krook J; Laurie J; Shreck R Cancer Treat Rep; 1983 Nov; 67(11):1001-8. PubMed ID: 6640551 [TBL] [Abstract][Full Text] [Related]
6. Chemotherapy of advanced colorectal carcinoma: fluorouracil alone vs. two drug combinations using fluorouracil, hydroxyurea, semustine, dacarbazine, razoxane, and mitomycin. A phase III trial by the Eastern Cooperative Oncology Group (EST: 1278). Engstrom PF; MacIntyre JM; Mittelman A; Klaassen DJ Am J Clin Oncol; 1984 Aug; 7(4):313-8. PubMed ID: 6377866 [TBL] [Abstract][Full Text] [Related]
7. Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients. Eastern Cooperative Oncology Group study (EST 3275). Engstrom PF; Lavin PT; Douglass HO; Brunner KW Cancer; 1985 May; 55(9):1868-73. PubMed ID: 3884131 [TBL] [Abstract][Full Text] [Related]
8. Chemotherapy of large bowel carcinoma--fluorouracil (FU) + hydroxyurea (HU) vs. methyl-CCNU, oncovin, fluorouracil, and streptozotocin (MOF-Strep). An Eastern Cooperative Oncology Group study. Engstrom PF; MacIntyre JM; Schutt AJ; Douglass HO Am J Clin Oncol; 1985 Oct; 8(5):358-61. PubMed ID: 2932908 [TBL] [Abstract][Full Text] [Related]
9. A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma. Buroker TR; Moertel CG; Fleming TR; Everson LK; Cullinan SA; Krook JE; Mailliard JA; Marschke RF; Klaassen DJ; Laurie JA J Clin Oncol; 1985 Dec; 3(12):1624-31. PubMed ID: 2933492 [TBL] [Abstract][Full Text] [Related]
11. Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. Gastrointestinal Tumor Study Group. J Clin Oncol; 1992 Apr; 10(4):549-57. PubMed ID: 1548520 [TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association. Richards F; Case LD; White DR; Muss HB; Spurr CL; Jackson DV; Cooper MR; Zekan P; Cruz J; Stuart JJ J Clin Oncol; 1986 Apr; 4(4):565-70. PubMed ID: 3514806 [TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy containing semustine (MeCCNU) in patients with advanced colorectal cancer previously treated with 5-fluorouracil (5-Fu). Engstrom PF; MacIntyre JM; Douglass HO; Muggia F; Mittelman A Am J Clin Oncol; 1983 Apr; 6(2):175-80. PubMed ID: 6829492 [TBL] [Abstract][Full Text] [Related]
14. Phase II/III study of doxorubicin with fluorouracil compared with streptozocin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: Eastern Cooperative Oncology Group Study E1281. Sun W; Lipsitz S; Catalano P; Mailliard JA; Haller DG; J Clin Oncol; 2005 Aug; 23(22):4897-904. PubMed ID: 16051944 [TBL] [Abstract][Full Text] [Related]
16. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.). Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954 [TBL] [Abstract][Full Text] [Related]
17. Hepatic artery infusion of 5-fluorouracil and mitomycin C in cholangiocarcinoma and gallbladder carcinoma. Smith GW; Bukowski RM; Hewlett JS; Groppe CW Cancer; 1984 Oct; 54(8):1513-6. PubMed ID: 6089991 [TBL] [Abstract][Full Text] [Related]
18. [MQF-FT and MQF-UFT in gallbladder and bile duct cancer]. Sakata Y; Fukushi G; Tsushima K; Suzuki H; Kimura T; Kimura M; Tamura Y; Kishibe T; Saitoh S; Itoh T Gan To Kagaku Ryoho; 1988 Sep; 15(9):2731-5. PubMed ID: 3137889 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated pancreatic, gallbladder, and bile duct carcinoma. Kruth J; Nissen J; Ernst T; Kripp M; Lukan N; Merx K; Hofmann WK; Hochhaus A; Hofheinz RD J Cancer Res Clin Oncol; 2010 Dec; 136(12):1845-51. PubMed ID: 20224968 [TBL] [Abstract][Full Text] [Related]
20. Metastatic colorectal carcinoma. A prospective randomized trial of Methyl-CCNU, 5-Fluorouracil (5-FU) and vincristine (MOF) versus MOF plus streptozotocin (MOF-Strep). Kemeny N; Yagoda A; Braun D Cancer; 1983 Jan; 51(1):20-4. PubMed ID: 6217886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]